Bauden, Monika <br/><br/>
In vitro cytotoxicity evaluation of HDAC inhibitor Apicidin in pancreatic carcinoma cells subsequent time and dose dependent treatment.  [electronic resource] 

 -  Toxicology letters  Jul 2015 
 - 8-15 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1879-3169 
<br/><br/><label>Standard No.: </label>10.1016/j.toxlet.2015.03.017  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--pharmacology<br/>Carcinoma--drug therapy<br/>Cell Line, Tumor<br/>Cell Proliferation--drug effects<br/>Cell Survival--drug effects<br/>DNA, Neoplasm--metabolism<br/>Histone Deacetylase Inhibitors--pharmacology<br/>Histone Deacetylases--chemistry<br/>Humans<br/>Inhibitory Concentration 50<br/>Kinetics<br/>Mitochondria--drug effects<br/>Mycotoxins--pharmacology<br/>Neoplasm Proteins--antagonists & inhibitors<br/>Pancreatic Neoplasms--drug therapy<br/>Peptides, Cyclic--pharmacology<br/>Reproducibility of Results